BeOne Medicines
ONC
#661
Rank
โ‚น3.197 T
Marketcap
โ‚น28,898
Share price
0.94%
Change (1 day)
64.04%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Earnings for BeOne Medicines (ONC)

Earnings in 2025 (TTM): โ‚น16.15 Billion

According to BeOne Medicines's latest financial reports the company's current earnings are โ‚น4.97 Billion. In 2024 the company made an earning of -โ‚น51.05 Billion, an increase over its 2023 earnings that were of -โ‚น108.5 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BeOne Medicines from 2015 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚น16.15 B-131.66%
2024 -โ‚น51.05 Billion-52.95%
2023 -โ‚น108.5 Billion-32.52%
2022 -โ‚น160.78 Billion24.39%
2021 -โ‚น129.25 Billion-13.21%
2020 -โ‚น148.92 Billion72.69%
2019 -โ‚น86.24 Billion36.01%
2018 -โ‚น63.41 Billion616.83%
2017 -โ‚น8.85 Billion-15.24%
2016 -โ‚น10.44 Billion107.91%
2015 -โ‚น5.02 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Onconova Therapeutics
ONTX
-โ‚น1.64 Billion-109.94%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-โ‚น14.33 Billion-187.30%๐Ÿ‡บ๐Ÿ‡ธ USA